Syngene A Good Play On Diversified Segments, API Price Recovery To Be Expected? | Vishal Manchanda

Vishal Manchanda, Senior VR, Institutional Group, Systematix Group, explains about the pharmaceutical company and products. He tells that after Covid-19 the pharma sector has fallen drastically. API pricing has come off and oral solid pricing has gone downwards. Furthermore, he tells about CDMO sector which provide help to pharma company, in which Syngene, a pharmaceutical company plays a vital role and expected to scale up in India.
#vishalmanchanda #systematixgroup #covid19 #cdmosector #syngene #pharmasector #api #apipricing #injectablespace #lauruslabs #divilabs #suven #solaraactive #iolchem #azithromycin #meropenem #pharmasector #genai #ussales #china #indianstockmarket #stockmarket #businessnews #etnow #nifty #niftyfifty #pharmaceuticalcompany
Subscribe To ET Now For Latest Updates On Stocks, Business, Trading | ► goo.gl/SEjvK3
Subscribe Now To Our Network Channels :-
Times Now : goo.gl/U9ibPb
The NewsHour Debate : goo.gl/LfNgFF
To Stay Updated Download the Times Now App :-
Android Google Play : goo.gl/zJhWjC
Apple App Store : goo.gl/d7QBQZ
Social Media Links :-
Twitter - goo.gl/hA0vDt
Facebook - goo.gl/5Lr4mC
G+ - goo.gl/hYxrmj
Website - www.etnownews.com